IDEAYA Biosciences, Inc. IDYA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -14.3%+17.1pp | -10.9%+21.7pp | -14.1%+7.0pp | -35.1%-13.6pp | -31.3%-11.0pp | |
| Return on assets | -13.1%+16.6pp | -10.2%+20.8pp | -13.3%+6.8pp | -32.9%-12.5pp | -29.8%-10.3pp | |
| Return on invested capital | -21.2%+20.0pp | -16.5%+28.3pp | -25.8%+13.0pp | -47.4%-14.1pp | -41.2%-12.2pp | |
| Liquidity | ||||||
| Current ratio | 10.7×-3.2× | 11.3×-3.6× | 12.4×-10.5× | 12.4×-5.1× | 13.9×-14.5× | |
| Quick ratio | 10.7×-3.2× | 11.3×-3.6× | 12.4×-10.5× | 12.4×-5.1× | 13.9×-14.5× | |
| Cash ratio | 2.4×-0.1× | 1.9×+0.1× | 4.6×-5.2× | 2.1×-2.4× | 2.6×-1.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $10.57-8.8% | $11.56-10.8% | $12.18-11.1% | $10.85-9.2% | $11.59-6.9% | |
| Valuation | ||||||
| Market capitalization | $2.93B+104% | $3.03B+36.4% | $2.38B-12.7% | $1.91B-30.3% | $1.43B-56.5% | |
| Enterprise value | $2.8B+110% | $2.95B+36.6% | $2.11B-10.0% | $1.82B-28.8% | $1.33B-58.3% | |
| Price / book | 3.1×+1.7× | 3×+0.9× | 2.2×-0.1× | 2×-1.0× | 1.4×-2.1× | |
| Free cash flow yield | -3%+15.7pp | -2.4%+8.9pp | -4.4%+1.2pp | -15.6%-10.7pp | -18.7%-14.6pp | |
| Earnings yield | -4.8%+16.6pp | -3.8%+8.6pp | -6.7%-0.2pp | -17.4%-11.8pp | -21.4%-17.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do IDEAYA Biosciences, Inc.'s ratios come from?
- Every ratio is computed from IDEAYA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
